Phathom Pharmaceuticals (PHAT) Shares Outstanding (2018 - 2026)

Phathom Pharmaceuticals (PHAT) has reported Shares Outstanding (Entity) for 9 consecutive years, with $80.9 million the latest figure, recorded in Q2 2026.

• In Q2 2026, Shares Outstanding (Entity) rose 15.4% year-over-year to $80.9 million; the TTM figure through Jun 2026 stood at $80.9 million (up 15.4% YoY), while the FY2025 annual figure was $71.4 million, up 4.23% from the prior year.
• Shares Outstanding (Entity) improved to $80.9 million in Q2 2026 per PHAT's latest filing, from $79.4 million in the prior quarter.
• Across five years, Shares Outstanding (Entity) topped out at $80.9 million in Q2 2026 and bottomed at $39.1 million in Q1 2022.
• Historically, Shares Outstanding (Entity) has averaged $59.6 million across 5 years, with a median of $58.6 million in 2024.
• Annual changes were most pronounced in 2023 — Shares Outstanding (Entity) surged 44.96% — and 2024, when it advanced 3.46%.
• Phathom Pharmaceuticals' Shares Outstanding (Entity) stood at $41.7 million in 2022, then soared by 38.94% to $58.0 million in 2023, then grew by 18.2% to $68.5 million in 2024, then grew by 4.23% to $71.4 million in 2025, then gained by 13.28% to $80.9 million in 2026.
• Business Quant data shows PHAT's Shares Outstanding (Entity) at $80.9 million in Q2 2026, $79.4 million in Q1 2026, and $71.4 million in Q4 2025.